Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$12,042,300
+$331,325 QoQ
Shares Held
33,255
-0.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.54%
of 13F equity value
Holder Rank
#489
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENEDICT FINANCIAL ADVISORS INC holds $49,408,945 across 8 Drug Manufacturers - General names. AMGN ranks #2 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,991 | $15,489,884 | |
| 2 | AMGN |
Amgen Inc
This page
|
33,255 | $12,042,300 | |
| 3 | ABBV |
AbbVie Inc.
|
47,038 | $11,836,642 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
70,088 | $4,038,470 | |
| 5 | NVS |
Novartis AG
|
17,055 | $2,672,859 | |
| 6 | NVO |
Novo Nordisk A S
|
33,754 | $1,618,166 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,812 | $1,492,328 | |
| 8 | LLY |
ELI LILLY & Co
|
182 | $218,296 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,042,300 | 33,255 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $11,710,975 | 33,284 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $11,017,581 | 33,661 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $9,492,361 | 33,637 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $9,315,004 | 33,362 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,311,993 | 33,099 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $8,481,486 | 32,541 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $10,400,294 | 32,278 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $10,137,440 | 32,445 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $9,344,461 | 32,866 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $9,508,692 | 33,014 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $8,821,240 | 32,822 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $7,230,525 | 32,567 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,725,846 | 31,958 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,263,442 | 31,463 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,162,310 | 31,776 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $7,700,931 | 31,652 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $7,521,085 | 31,102 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $6,851,461 | 30,455 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $6,279,341 | 29,529 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $7,000,987 | 28,722 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $7,020,174 | 28,215 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $6,410,399 | 27,881 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $6,959,917 | 27,384 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $6,335,671 | 26,862 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $5,432,758 | 26,798 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||